Jantz Derek's Form 4 filing
Precision Biosciences IncDTIL · filed Jun 9, 2022
- Accession no.
- 0001209191-22-035417
- Filed
- Jun 9, 2022
- Trade date
- Jun 7-8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $38.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jantz DerekCIK 0001769828 | Director, Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 | Common Stock | MOption exerciseAcquired | +29,545 | –F2 | – | 4,061,824 | Direct | |
| Jun 7, 2022 | Common Stock | MOption exerciseAcquired | +12,199 | –F2 | – | 4,074,023 | Direct | |
| Jun 8, 2022 | Common Stock | SSaleDisposed | −18,849 | $2.06 | −$38,828.94 | 4,055,174 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 | Common Stock | MOption exerciseDisposed | −29,545 | $0.00 | $0 | 29,545 | Direct | |
| Jun 7, 2022 | Common Stock | MOption exerciseDisposed | −12,199 | $0.00 | $0 | 24,391 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each RSU represents a contingent right to receive one share of the Company's Common Stock.
Referenced by the price of 2 transactions in Table I.